Protocols
1 protocol(s) meet the specified criteria
Drug: PANITUMUMAB
Protocol No.TitleStatus
LCCC1632Phase II Trial of Panitumumab, Nivolumab, and Ipilimumab for KRAS/NRAS/BRAF Wild-type MSS Refractory Metastatic Colorectal AdenocarcinomaOpen